Transdermal Testosterone 300 mcg/day
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Transdermal Testosterone 300 mcg/day, covering 2011-12-15 to 2011-12-15. Get the full timeline:
Most recent: Clinical Trial Update: Endometrial Safety Study of Transdermal Testosterone (300 Mcg/Day) in Naturally Postmenopausal Women [Phase 3]